"Vitreous Body" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.
Concept/Terms
Vitreous Body- Vitreous Body
- Bodies, Vitreous
- Body, Vitreous
- Vitreous Bodies
- Vitreous Humor
- Humor, Vitreous
- Humors, Vitreous
- Vitreous Humors
Below are MeSH descriptors whose meaning is more general than "Vitreous Body".
Below are MeSH descriptors whose meaning is more specific than "Vitreous Body".
This graph shows the total number of publications written about "Vitreous Body" by people in Harvard Catalyst Profiles by year, and whether "Vitreous Body" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 2 | 5 |
| 1995 | 2 | 3 | 5 |
| 1996 | 1 | 4 | 5 |
| 1997 | 1 | 3 | 4 |
| 1998 | 2 | 2 | 4 |
| 1999 | 6 | 1 | 7 |
| 2000 | 4 | 5 | 9 |
| 2001 | 1 | 4 | 5 |
| 2002 | 1 | 3 | 4 |
| 2003 | 2 | 3 | 5 |
| 2004 | 4 | 2 | 6 |
| 2005 | 3 | 10 | 13 |
| 2006 | 1 | 13 | 14 |
| 2007 | 3 | 15 | 18 |
| 2008 | 3 | 9 | 12 |
| 2009 | 6 | 15 | 21 |
| 2010 | 6 | 9 | 15 |
| 2011 | 5 | 5 | 10 |
| 2012 | 3 | 3 | 6 |
| 2013 | 4 | 4 | 8 |
| 2014 | 6 | 1 | 7 |
| 2015 | 6 | 3 | 9 |
| 2016 | 5 | 4 | 9 |
| 2017 | 6 | 2 | 8 |
| 2018 | 4 | 3 | 7 |
| 2019 | 3 | 2 | 5 |
| 2020 | 6 | 2 | 8 |
| 2021 | 4 | 3 | 7 |
| 2022 | 1 | 3 | 4 |
| 2024 | 0 | 2 | 2 |
Below are the most recent publications written about "Vitreous Body" by people in Profiles.
-
Proliferative Vitreoretinopathy: Pathophysiology and Therapeutic Approaches. Int Ophthalmol Clin. 2024 Apr 01; 64(2):125-135.
-
Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection. PLoS One. 2024; 19(1):e0294526.
-
Cytomegalovirus retinitis and immune recovery uveitis in a pediatric patient with leukemia. J AAPOS. 2023 02; 27(1):52-55.
-
Elevated Retinol Binding Protein 3 Concentrations Are Associated With Decreased Vitreous Inflammatory Cytokines, VEGF, and Progression of Diabetic Retinopathy. Diabetes Care. 2022 09 01; 45(9):2159-2162.
-
Challenges and Updates on the Management of Acute Retinal Necrosis. Int Ophthalmol Clin. 2022 Apr 01; 62(2):173-196.
-
Clinical Outcomes in Vitrectomized versus Non-vitrectomized Eyes in Patients with Primary Vitreoretinal Lymphoma. Ocul Immunol Inflamm. 2023 Apr; 31(3):496-500.
-
A protocol to inject ocular drug implants into mouse eyes. STAR Protoc. 2022 03 18; 3(1):101143.
-
An intravitreal implant injection method for sustained drug delivery into mouse eyes. Cell Rep Methods. 2021 12 20; 1(8).
-
PRO score: predictive scoring system for visual outcomes after rhegmatogenous retinal detachment repair. Br J Ophthalmol. 2023 04; 107(4):555-559.
-
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2022 03; 129(3):295-307.